Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.91626230 |
2 | synaptic vesicle maturation (GO:0016188) | 5.75971097 |
3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.48233646 |
4 | locomotory exploration behavior (GO:0035641) | 5.13176759 |
5 | synaptic vesicle exocytosis (GO:0016079) | 5.12441081 |
6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.12150219 |
7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.84663669 |
8 | glutamate secretion (GO:0014047) | 4.82472125 |
9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.71428150 |
10 | vocalization behavior (GO:0071625) | 4.64198405 |
11 | layer formation in cerebral cortex (GO:0021819) | 4.63426792 |
12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.57008716 |
13 | NADH metabolic process (GO:0006734) | 4.53108216 |
14 | regulation of synaptic vesicle transport (GO:1902803) | 4.47588316 |
15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.45859535 |
16 | regulation of synapse structural plasticity (GO:0051823) | 4.42902350 |
17 | neurotransmitter secretion (GO:0007269) | 4.29736285 |
18 | sodium ion export (GO:0071436) | 4.27443789 |
19 | muscle filament sliding (GO:0030049) | 4.23370663 |
20 | actin-myosin filament sliding (GO:0033275) | 4.23370663 |
21 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.15733818 |
22 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.12247928 |
23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.07584991 |
24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.03020855 |
25 | neuronal action potential propagation (GO:0019227) | 3.98696427 |
26 | cellular potassium ion homeostasis (GO:0030007) | 3.95638867 |
27 | skeletal muscle contraction (GO:0003009) | 3.95471077 |
28 | activation of protein kinase A activity (GO:0034199) | 3.95261506 |
29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.91589371 |
30 | exploration behavior (GO:0035640) | 3.90054614 |
31 | regulation of early endosome to late endosome transport (GO:2000641) | 3.86157628 |
32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.83691836 |
33 | gamma-aminobutyric acid transport (GO:0015812) | 3.83192611 |
34 | cell communication by electrical coupling (GO:0010644) | 3.78858793 |
35 | protein localization to synapse (GO:0035418) | 3.73621228 |
36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.70025216 |
37 | adherens junction assembly (GO:0034333) | 3.66502586 |
38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.65989054 |
39 | focal adhesion assembly (GO:0048041) | 3.65978522 |
40 | cell-substrate adherens junction assembly (GO:0007045) | 3.65978522 |
41 | regulation of ARF protein signal transduction (GO:0032012) | 3.64367174 |
42 | positive regulation of synapse maturation (GO:0090129) | 3.63631612 |
43 | negative regulation of cell size (GO:0045792) | 3.63538034 |
44 | positive regulation of membrane potential (GO:0045838) | 3.62101539 |
45 | barbed-end actin filament capping (GO:0051016) | 3.56799311 |
46 | neuromuscular process controlling posture (GO:0050884) | 3.55671779 |
47 | dendritic spine morphogenesis (GO:0060997) | 3.54568402 |
48 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.53197402 |
49 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.51026917 |
50 | actin-mediated cell contraction (GO:0070252) | 3.48036489 |
51 | proline transport (GO:0015824) | 3.46986533 |
52 | prepulse inhibition (GO:0060134) | 3.46738596 |
53 | synaptic transmission, glutamatergic (GO:0035249) | 3.46713941 |
54 | long-term memory (GO:0007616) | 3.45646305 |
55 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.44931361 |
56 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.43946308 |
57 | low-density lipoprotein particle clearance (GO:0034383) | 3.40703850 |
58 | neuron cell-cell adhesion (GO:0007158) | 3.38734250 |
59 | creatine metabolic process (GO:0006600) | 3.37706053 |
60 | synaptic vesicle endocytosis (GO:0048488) | 3.36683323 |
61 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.32165539 |
62 | positive regulation of receptor recycling (GO:0001921) | 3.31297036 |
63 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.30158885 |
64 | neurotransmitter transport (GO:0006836) | 3.28585903 |
65 | neuron-neuron synaptic transmission (GO:0007270) | 3.24831742 |
66 | protein localization to endosome (GO:0036010) | 3.24571733 |
67 | glutamate receptor signaling pathway (GO:0007215) | 3.22011028 |
68 | cell-substrate junction assembly (GO:0007044) | 3.20945783 |
69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.18150944 |
70 | cerebellar Purkinje cell layer development (GO:0021680) | 3.15994201 |
71 | negative regulation of microtubule polymerization (GO:0031115) | 3.15738041 |
72 | regulation of neurotransmitter levels (GO:0001505) | 3.15267908 |
73 | regulation of synaptic plasticity (GO:0048167) | 3.14415050 |
74 | neuromuscular process controlling balance (GO:0050885) | 3.13610934 |
75 | regulation of postsynaptic membrane potential (GO:0060078) | 3.13543620 |
76 | stress fiber assembly (GO:0043149) | 3.11625617 |
77 | dopamine receptor signaling pathway (GO:0007212) | 3.10827859 |
78 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.08268312 |
79 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07653909 |
80 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.07069491 |
81 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.06484890 |
82 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.06438895 |
83 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.05224956 |
84 | positive regulation of protein dephosphorylation (GO:0035307) | 3.04600780 |
85 | detection of calcium ion (GO:0005513) | 3.03696045 |
86 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.02022993 |
87 | skeletal muscle fiber development (GO:0048741) | 2.99287353 |
88 | glycogen catabolic process (GO:0005980) | 2.98860405 |
89 | cell communication involved in cardiac conduction (GO:0086065) | 2.96767181 |
90 | signal complex assembly (GO:0007172) | 2.95786498 |
91 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.95774240 |
92 | mating behavior (GO:0007617) | 2.94531375 |
93 | positive regulation of myotube differentiation (GO:0010831) | 2.93382856 |
94 | positive regulation of dendritic spine development (GO:0060999) | 2.92741405 |
95 | membrane depolarization during action potential (GO:0086010) | 2.92040227 |
96 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.91361784 |
97 | glycine transport (GO:0015816) | 2.89841729 |
98 | regulation of skeletal muscle contraction (GO:0014819) | 2.89223155 |
99 | striated muscle contraction (GO:0006941) | 2.89137263 |
100 | regulation of vesicle fusion (GO:0031338) | 2.88870737 |
101 | cellular sodium ion homeostasis (GO:0006883) | 2.88698947 |
102 | actin filament-based movement (GO:0030048) | 2.86062011 |
103 | dendrite morphogenesis (GO:0048813) | 2.84907209 |
104 | glucan catabolic process (GO:0009251) | 2.82884178 |
105 | apoptotic process involved in morphogenesis (GO:0060561) | 2.82058198 |
106 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.81993391 |
107 | intraspecies interaction between organisms (GO:0051703) | 2.81549702 |
108 | social behavior (GO:0035176) | 2.81549702 |
109 | neuron recognition (GO:0008038) | 2.80159713 |
110 | protein targeting to plasma membrane (GO:0072661) | 2.79807752 |
111 | vesicle transport along microtubule (GO:0047496) | 2.75998619 |
112 | membrane repolarization (GO:0086009) | 2.75724149 |
113 | dendritic spine organization (GO:0097061) | 2.75334059 |
114 | membrane depolarization (GO:0051899) | 2.74917888 |
115 | potassium ion import (GO:0010107) | 2.74914765 |
116 | regulation of dendritic spine development (GO:0060998) | 2.74203124 |
117 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.74032281 |
118 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.73590932 |
119 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.73399400 |
120 | triglyceride catabolic process (GO:0019433) | 2.73270107 |
121 | basement membrane organization (GO:0071711) | 2.72803387 |
122 | regulation of neurotransmitter secretion (GO:0046928) | 2.71923515 |
123 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.71211990 |
124 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.70380674 |
125 | organelle transport along microtubule (GO:0072384) | 2.69681808 |
126 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.69454919 |
127 | regulation of sequestering of triglyceride (GO:0010889) | 2.69142653 |
128 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.68912807 |
129 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.68461108 |
130 | long-term synaptic potentiation (GO:0060291) | 2.68423962 |
131 | maternal placenta development (GO:0001893) | 2.68210533 |
132 | gluconeogenesis (GO:0006094) | 2.66950081 |
133 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.66656162 |
134 | response to pheromone (GO:0019236) | 2.66257211 |
135 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.65625619 |
136 | negative regulation of fatty acid transport (GO:2000192) | 2.64968782 |
137 | innervation (GO:0060384) | 2.64352936 |
138 | membrane hyperpolarization (GO:0060081) | 2.64010726 |
139 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.63742390 |
140 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.63400836 |
141 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.63400836 |
142 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.62689110 |
143 | plasma membrane repair (GO:0001778) | 2.62217674 |
144 | striatum development (GO:0021756) | 2.61634997 |
145 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.60646666 |
146 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.60375921 |
147 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.60332059 |
148 | cellular polysaccharide catabolic process (GO:0044247) | 2.58099403 |
149 | skeletal muscle adaptation (GO:0043501) | 2.57939195 |
150 | cellular response to epinephrine stimulus (GO:0071872) | 2.57256049 |
151 | acylglycerol catabolic process (GO:0046464) | 2.56424890 |
152 | neutral lipid catabolic process (GO:0046461) | 2.56424890 |
153 | cellular response to nutrient (GO:0031670) | 2.54925199 |
154 | glucan biosynthetic process (GO:0009250) | 2.54681208 |
155 | glycogen biosynthetic process (GO:0005978) | 2.54681208 |
156 | cardiac muscle contraction (GO:0060048) | 2.54143908 |
157 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.52753293 |
158 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.50828416 |
159 | response to parathyroid hormone (GO:0071107) | 2.50142497 |
160 | myofibril assembly (GO:0030239) | 2.47078628 |
161 | protein retention in ER lumen (GO:0006621) | 2.45861305 |
162 | sarcomere organization (GO:0045214) | 2.45320803 |
163 | cellular response to catecholamine stimulus (GO:0071870) | 2.45035460 |
164 | cellular response to monoamine stimulus (GO:0071868) | 2.45035460 |
165 | myoblast fusion (GO:0007520) | 2.43026023 |
166 | hexose biosynthetic process (GO:0019319) | 2.41335772 |
167 | negative regulation of necroptotic process (GO:0060546) | 2.40975515 |
168 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.40897008 |
169 | regulation of necrotic cell death (GO:0010939) | 2.39516482 |
170 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.38170424 |
171 | fatty acid homeostasis (GO:0055089) | 2.36683378 |
172 | regulation of protein dephosphorylation (GO:0035304) | 2.36372299 |
173 | regulation of receptor recycling (GO:0001919) | 2.35846740 |
174 | adhesion of symbiont to host cell (GO:0044650) | 2.35806753 |
175 | virion attachment to host cell (GO:0019062) | 2.35806753 |
176 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.34696855 |
177 | fructose metabolic process (GO:0006000) | 2.34129652 |
178 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.33081631 |
179 | muscle contraction (GO:0006936) | 2.31303452 |
180 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.30867301 |
181 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.30643516 |
182 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.30557645 |
183 | glycogen metabolic process (GO:0005977) | 2.30138451 |
184 | myotube cell development (GO:0014904) | 2.29170144 |
185 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.27509954 |
186 | metanephric nephron epithelium development (GO:0072243) | 2.26970894 |
187 | polysaccharide catabolic process (GO:0000272) | 2.26361769 |
188 | cellular glucan metabolic process (GO:0006073) | 2.26224678 |
189 | glucan metabolic process (GO:0044042) | 2.26224678 |
190 | actin filament depolymerization (GO:0030042) | 2.25743235 |
191 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.25188782 |
192 | response to muscle activity (GO:0014850) | 2.22524547 |
193 | epithelial cell-cell adhesion (GO:0090136) | 2.21967399 |
194 | Golgi transport vesicle coating (GO:0048200) | 2.21522976 |
195 | COPI coating of Golgi vesicle (GO:0048205) | 2.21522976 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.29063322 |
2 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.61887409 |
3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.18462269 |
4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.17242263 |
5 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.08408144 |
6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.04194576 |
7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.88062349 |
8 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.81521524 |
9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.76080659 |
10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68394867 |
11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.68298290 |
12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.62927972 |
13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.56607567 |
14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.49752902 |
15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48411990 |
16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.46509250 |
17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.39766886 |
18 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.38089363 |
19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.35223298 |
20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35106561 |
21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.25939101 |
22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.25939101 |
23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22242916 |
24 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.19922988 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19676964 |
26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.16260171 |
27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15532220 |
28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13207340 |
29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12607860 |
30 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.05930517 |
31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.05819650 |
32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.05608618 |
33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.01619963 |
34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.01616568 |
35 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.97412202 |
36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95539837 |
37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.89635012 |
38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.85790891 |
39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.85336145 |
40 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.84138918 |
41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.81302900 |
42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.80681295 |
43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.79894552 |
44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.77752923 |
45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.75899774 |
46 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.69746661 |
47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.69565314 |
48 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.68385922 |
49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66830472 |
50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65957667 |
51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.64527850 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64116424 |
53 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.61148520 |
54 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59972717 |
55 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59621797 |
56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59283852 |
57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.59157377 |
58 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.54448268 |
59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52763203 |
60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51127380 |
61 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.49362730 |
62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.47395551 |
63 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44132082 |
64 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.39137460 |
65 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.38917947 |
66 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.38697317 |
67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.38697317 |
68 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.36262817 |
69 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35191504 |
70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33650522 |
71 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.32922890 |
72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32143485 |
73 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.31183991 |
74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.30501741 |
75 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28150507 |
76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25991198 |
77 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24228359 |
78 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.23856864 |
79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22973286 |
80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.21497584 |
81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20436031 |
82 | AR_19668381_ChIP-Seq_PC3_Human | 1.19808367 |
83 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.18168198 |
84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18037223 |
85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17517020 |
86 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17307841 |
87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16549508 |
88 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16072426 |
89 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.15374493 |
90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14668614 |
91 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14108153 |
92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13797580 |
93 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13692396 |
94 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13331519 |
95 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.12699773 |
96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11370271 |
97 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10877699 |
98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10024933 |
99 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09624806 |
100 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08566513 |
101 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06539662 |
102 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06232981 |
103 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.05977321 |
104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05604526 |
105 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05225122 |
106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05058103 |
107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.03696723 |
108 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03474635 |
109 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.03382419 |
110 | P68_20966046_ChIP-Seq_HELA_Human | 1.03134869 |
111 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02616661 |
112 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02245294 |
113 | MAF_26560356_Chip-Seq_TH2_Human | 1.01736759 |
114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01378395 |
115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01040804 |
116 | MYC_22102868_ChIP-Seq_BL_Human | 1.00985138 |
117 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.00692813 |
118 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00664033 |
119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00097593 |
120 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00096786 |
121 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.99561524 |
122 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99509568 |
123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99449774 |
124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99069305 |
125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.98568740 |
126 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98301189 |
127 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97927303 |
128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97864179 |
129 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96647557 |
130 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.95652200 |
131 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.95501662 |
132 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94470106 |
133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93880495 |
134 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.93310653 |
135 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92455900 |
136 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91476261 |
137 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89646080 |
138 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.89207406 |
139 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87569702 |
140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87412425 |
141 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86239617 |
142 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85978248 |
143 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85104406 |
144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83491406 |
145 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83409398 |
146 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.81620837 |
147 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.81555009 |
148 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.81438538 |
149 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.80685965 |
150 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.79541108 |
151 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79055522 |
152 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.78494366 |
153 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78031550 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.31868095 |
2 | MP0003705_abnormal_hypodermis_morpholog | 4.80908355 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.94769408 |
4 | MP0003880_abnormal_central_pattern | 3.91577957 |
5 | MP0002822_catalepsy | 3.50788388 |
6 | MP0004270_analgesia | 3.50387386 |
7 | MP0004185_abnormal_adipocyte_glucose | 3.29797000 |
8 | MP0000749_muscle_degeneration | 3.03389695 |
9 | MP0002063_abnormal_learning/memory/cond | 2.99563804 |
10 | MP0005666_abnormal_adipose_tissue | 2.95470331 |
11 | MP0009745_abnormal_behavioral_response | 2.83770013 |
12 | MP0002909_abnormal_adrenal_gland | 2.81756557 |
13 | MP0005670_abnormal_white_adipose | 2.75175610 |
14 | MP0002064_seizures | 2.71558625 |
15 | MP0005451_abnormal_body_composition | 2.66314845 |
16 | MP0005423_abnormal_somatic_nervous | 2.58380852 |
17 | MP0005058_abnormal_lysosome_morphology | 2.53813381 |
18 | MP0005375_adipose_tissue_phenotype | 2.50747833 |
19 | MP0000759_abnormal_skeletal_muscle | 2.46569698 |
20 | MP0008438_abnormal_cutaneous_collagen | 2.46373920 |
21 | MP0002572_abnormal_emotion/affect_behav | 2.31162366 |
22 | MP0001968_abnormal_touch/_nociception | 2.29099188 |
23 | MP0003329_amyloid_beta_deposits | 2.26386662 |
24 | MP0009840_abnormal_foam_cell | 2.23329793 |
25 | MP0002877_abnormal_melanocyte_morpholog | 2.16619681 |
26 | MP0003191_abnormal_cellular_cholesterol | 2.08683059 |
27 | MP0002734_abnormal_mechanical_nocicepti | 2.07123526 |
28 | MP0002837_dystrophic_cardiac_calcinosis | 2.06533898 |
29 | MP0004087_abnormal_muscle_fiber | 2.06473881 |
30 | MP0002272_abnormal_nervous_system | 2.04798212 |
31 | MP0002971_abnormal_brown_adipose | 2.03946303 |
32 | MP0000733_abnormal_muscle_development | 2.01986666 |
33 | MP0009046_muscle_twitch | 2.00248168 |
34 | MP0008961_abnormal_basal_metabolism | 1.97536112 |
35 | MP0009780_abnormal_chondrocyte_physiolo | 1.96778066 |
36 | MP0002733_abnormal_thermal_nociception | 1.95363550 |
37 | MP0004858_abnormal_nervous_system | 1.93219091 |
38 | MP0003283_abnormal_digestive_organ | 1.90270585 |
39 | MP0008569_lethality_at_weaning | 1.89328135 |
40 | MP0010234_abnormal_vibrissa_follicle | 1.84499199 |
41 | MP0001486_abnormal_startle_reflex | 1.80634523 |
42 | MP0004811_abnormal_neuron_physiology | 1.77986250 |
43 | MP0000013_abnormal_adipose_tissue | 1.76260258 |
44 | MP0000750_abnormal_muscle_regeneration | 1.72742149 |
45 | MP0001501_abnormal_sleep_pattern | 1.72724057 |
46 | MP0002332_abnormal_exercise_endurance | 1.68339747 |
47 | MP0001970_abnormal_pain_threshold | 1.67869951 |
48 | MP0002736_abnormal_nociception_after | 1.67788619 |
49 | MP0002796_impaired_skin_barrier | 1.63097984 |
50 | MP0002735_abnormal_chemical_nociception | 1.59072882 |
51 | MP0001958_emphysema | 1.58496561 |
52 | MP0000751_myopathy | 1.58262801 |
53 | MP0001440_abnormal_grooming_behavior | 1.56864891 |
54 | MP0005386_behavior/neurological_phenoty | 1.56426681 |
55 | MP0004924_abnormal_behavior | 1.56426681 |
56 | MP0002106_abnormal_muscle_physiology | 1.51688700 |
57 | MP0008260_abnormal_autophagy | 1.49788597 |
58 | MP0003279_aneurysm | 1.49311969 |
59 | MP0005623_abnormal_meninges_morphology | 1.48767751 |
60 | MP0002557_abnormal_social/conspecific_i | 1.48618739 |
61 | MP0005275_abnormal_skin_tensile | 1.48479927 |
62 | MP0002234_abnormal_pharynx_morphology | 1.45041242 |
63 | MP0002067_abnormal_sensory_capabilities | 1.44881108 |
64 | MP0003566_abnormal_cell_adhesion | 1.44035439 |
65 | MP0002184_abnormal_innervation | 1.43562908 |
66 | MP0000955_abnormal_spinal_cord | 1.42045342 |
67 | MP0005409_darkened_coat_color | 1.37114768 |
68 | MP0006138_congestive_heart_failure | 1.36154405 |
69 | MP0000569_abnormal_digit_pigmentation | 1.35876933 |
70 | MP0005369_muscle_phenotype | 1.34634903 |
71 | MP0003453_abnormal_keratinocyte_physiol | 1.33867931 |
72 | MP0002139_abnormal_hepatobiliary_system | 1.33012785 |
73 | MP0001849_ear_inflammation | 1.31685544 |
74 | MP0002108_abnormal_muscle_morphology | 1.31452103 |
75 | MP0004233_abnormal_muscle_weight | 1.29538305 |
76 | MP0005330_cardiomyopathy | 1.28719919 |
77 | MP0004145_abnormal_muscle_electrophysio | 1.27260682 |
78 | MP0010030_abnormal_orbit_morphology | 1.27174925 |
79 | MP0003633_abnormal_nervous_system | 1.25633696 |
80 | MP0002066_abnormal_motor_capabilities/c | 1.25313411 |
81 | MP0000604_amyloidosis | 1.23831217 |
82 | MP0003091_abnormal_cell_migration | 1.21173167 |
83 | MP0005620_abnormal_muscle_contractility | 1.21071260 |
84 | MP0003879_abnormal_hair_cell | 1.20667249 |
85 | MP0003828_pulmonary_edema | 1.19845010 |
86 | MP0004043_abnormal_pH_regulation | 1.17795901 |
87 | MP0005646_abnormal_pituitary_gland | 1.15578452 |
88 | MP0001346_abnormal_lacrimal_gland | 1.14616465 |
89 | MP0004215_abnormal_myocardial_fiber | 1.13963079 |
90 | MP0001529_abnormal_vocalization | 1.13347668 |
91 | MP0003787_abnormal_imprinting | 1.11924573 |
92 | MP0006276_abnormal_autonomic_nervous | 1.11788470 |
93 | MP0002249_abnormal_larynx_morphology | 1.11644861 |
94 | MP0008872_abnormal_physiological_respon | 1.10407829 |
95 | MP0003303_peritoneal_inflammation | 1.10303949 |
96 | MP0000778_abnormal_nervous_system | 1.10232158 |
97 | MP0005535_abnormal_body_temperature | 1.09335832 |
98 | MP0002970_abnormal_white_adipose | 1.09163797 |
99 | MP0002882_abnormal_neuron_morphology | 1.08757249 |
100 | MP0005360_urolithiasis | 1.08664715 |
101 | MP0003075_altered_response_to | 1.07821724 |
102 | MP0002069_abnormal_eating/drinking_beha | 1.07584119 |
103 | MP0005076_abnormal_cell_differentiation | 1.06485262 |
104 | MP0003172_abnormal_lysosome_physiology | 1.05854503 |
105 | MP0000678_abnormal_parathyroid_gland | 1.05741697 |
106 | MP0008874_decreased_physiological_sensi | 1.01378255 |
107 | MP0005365_abnormal_bile_salt | 1.01332211 |
108 | MP0001661_extended_life_span | 1.00876148 |
109 | MP0004510_myositis | 1.00671505 |
110 | MP0004085_abnormal_heartbeat | 1.00547991 |
111 | MP0000747_muscle_weakness | 1.00180716 |
112 | MP0001984_abnormal_olfaction | 0.99915140 |
113 | MP0004130_abnormal_muscle_cell | 0.98568470 |
114 | MP0005645_abnormal_hypothalamus_physiol | 0.98461070 |
115 | MP0005501_abnormal_skin_physiology | 0.97404379 |
116 | MP0010630_abnormal_cardiac_muscle | 0.97185534 |
117 | MP0009379_abnormal_foot_pigmentation | 0.97108825 |
118 | MP0002269_muscular_atrophy | 0.96759099 |
119 | MP0002152_abnormal_brain_morphology | 0.96485939 |
120 | MP0005085_abnormal_gallbladder_physiolo | 0.96400251 |
121 | MP0002972_abnormal_cardiac_muscle | 0.95950500 |
122 | MP0001502_abnormal_circadian_rhythm | 0.95546847 |
123 | MP0002060_abnormal_skin_morphology | 0.95103802 |
124 | MP0001348_abnormal_lacrimal_gland | 0.94599886 |
125 | MP0003631_nervous_system_phenotype | 0.93370371 |
126 | MP0004885_abnormal_endolymph | 0.92952688 |
127 | MP0003646_muscle_fatigue | 0.92751378 |
128 | MP0005503_abnormal_tendon_morphology | 0.92689102 |
129 | MP0001765_abnormal_ion_homeostasis | 0.91121417 |
130 | MP0005166_decreased_susceptibility_to | 0.88949606 |
131 | MP0003959_abnormal_lean_body | 0.86122320 |
132 | MP0002896_abnormal_bone_mineralization | 0.85785759 |
133 | MP0006036_abnormal_mitochondrial_physio | 0.85349341 |
134 | MP0002078_abnormal_glucose_homeostasis | 0.85083552 |
135 | MP0003137_abnormal_impulse_conducting | 0.84145330 |
136 | MP0004084_abnormal_cardiac_muscle | 0.83950501 |
137 | MP0005499_abnormal_olfactory_system | 0.82932814 |
138 | MP0005394_taste/olfaction_phenotype | 0.82932814 |
139 | MP0009115_abnormal_fat_cell | 0.82773577 |
140 | MP0005023_abnormal_wound_healing | 0.81791734 |
141 | MP0002229_neurodegeneration | 0.80586441 |
142 | MP0002090_abnormal_vision | 0.80013880 |
143 | MP0005187_abnormal_penis_morphology | 0.79247409 |
144 | MP0005167_abnormal_blood-brain_barrier | 0.79190927 |
145 | MP0001944_abnormal_pancreas_morphology | 0.79101074 |
146 | MP0000343_altered_response_to | 0.79054791 |
147 | MP0000003_abnormal_adipose_tissue | 0.78443020 |
148 | MP0003122_maternal_imprinting | 0.78123084 |
149 | MP0005083_abnormal_biliary_tract | 0.78087705 |
150 | MP0005334_abnormal_fat_pad | 0.77205270 |
151 | MP0000767_abnormal_smooth_muscle | 0.77195558 |
152 | MP0010368_abnormal_lymphatic_system | 0.77129386 |
153 | MP0000858_altered_metastatic_potential | 0.76932874 |
154 | MP0003123_paternal_imprinting | 0.75959049 |
155 | MP0003252_abnormal_bile_duct | 0.75296791 |
156 | MP0005165_increased_susceptibility_to | 0.73285946 |
157 | MP0001905_abnormal_dopamine_level | 0.70866646 |
158 | MP0004272_abnormal_basement_membrane | 0.70673159 |
159 | MP0004036_abnormal_muscle_relaxation | 0.70656316 |
160 | MP0001542_abnormal_bone_strength | 0.69175581 |
161 | MP0001664_abnormal_digestion | 0.67985996 |
162 | MP0005385_cardiovascular_system_phenoty | 0.67859251 |
163 | MP0001544_abnormal_cardiovascular_syste | 0.67859251 |
164 | MP0002693_abnormal_pancreas_physiology | 0.67719682 |
165 | MP0004947_skin_inflammation | 0.66594788 |
166 | MP0000681_abnormal_thyroid_gland | 0.65781784 |
167 | MP0006035_abnormal_mitochondrial_morpho | 0.65750283 |
168 | MP0010329_abnormal_lipoprotein_level | 0.64724805 |
169 | MP0004484_altered_response_of | 0.64574006 |
170 | MP0002998_abnormal_bone_remodeling | 0.63377036 |
171 | MP0005257_abnormal_intraocular_pressure | 0.63353467 |
172 | MP0001666_abnormal_nutrient_absorption | 0.62924705 |
173 | MP0003300_gastrointestinal_ulcer | 0.62786770 |
174 | MP0003953_abnormal_hormone_level | 0.62672999 |
175 | MP0005452_abnormal_adipose_tissue | 0.61585969 |
176 | MP0005595_abnormal_vascular_smooth | 0.61564836 |
177 | MP0010352_gastrointestinal_tract_polyps | 0.58754807 |
178 | MP0000462_abnormal_digestive_system | 0.58712279 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Type 1 muscle fiber predominance (HP:0003803) | 5.56750964 |
2 | Muscle fiber inclusion bodies (HP:0100299) | 5.55832441 |
3 | Myokymia (HP:0002411) | 5.54037516 |
4 | Nemaline bodies (HP:0003798) | 5.50585344 |
5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.37861072 |
6 | Focal motor seizures (HP:0011153) | 4.98897154 |
7 | Visual hallucinations (HP:0002367) | 4.83623712 |
8 | Focal seizures (HP:0007359) | 4.27060686 |
9 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.10790818 |
10 | Increased variability in muscle fiber diameter (HP:0003557) | 4.07256300 |
11 | Myopathic facies (HP:0002058) | 3.79655767 |
12 | Distal lower limb muscle weakness (HP:0009053) | 3.78587196 |
13 | Increased connective tissue (HP:0009025) | 3.70327976 |
14 | Atonic seizures (HP:0010819) | 3.57314805 |
15 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.52382304 |
16 | Supranuclear gaze palsy (HP:0000605) | 3.50304503 |
17 | Distal lower limb amyotrophy (HP:0008944) | 3.45884654 |
18 | Epileptic encephalopathy (HP:0200134) | 3.41608175 |
19 | Hyporeflexia of lower limbs (HP:0002600) | 3.41511615 |
20 | Bundle branch block (HP:0011710) | 3.36805778 |
21 | Spinal rigidity (HP:0003306) | 3.33080863 |
22 | Abnormality of the lower motor neuron (HP:0002366) | 3.32872322 |
23 | Absence seizures (HP:0002121) | 3.30081650 |
24 | Round ear (HP:0100830) | 3.29703516 |
25 | Action tremor (HP:0002345) | 3.28321990 |
26 | Asymmetric septal hypertrophy (HP:0001670) | 3.25437879 |
27 | Protrusio acetabuli (HP:0003179) | 3.22059801 |
28 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.16484626 |
29 | Papilledema (HP:0001085) | 3.16078429 |
30 | EMG: myopathic abnormalities (HP:0003458) | 3.15089849 |
31 | Muscle fiber splitting (HP:0003555) | 3.13732658 |
32 | Depression (HP:0000716) | 3.09667225 |
33 | Poor eye contact (HP:0000817) | 3.09163915 |
34 | Impaired social interactions (HP:0000735) | 3.06646327 |
35 | Abnormal social behavior (HP:0012433) | 3.06646327 |
36 | Rhabdomyolysis (HP:0003201) | 3.02155392 |
37 | Ulnar deviation of the wrist (HP:0003049) | 3.01399121 |
38 | Distal arthrogryposis (HP:0005684) | 2.94813452 |
39 | Neck muscle weakness (HP:0000467) | 2.94603644 |
40 | Generalized tonic-clonic seizures (HP:0002069) | 2.93221256 |
41 | Ankle clonus (HP:0011448) | 2.91540842 |
42 | Difficulty running (HP:0009046) | 2.89693033 |
43 | Bulbar palsy (HP:0001283) | 2.87366906 |
44 | Pheochromocytoma (HP:0002666) | 2.87080318 |
45 | Dialeptic seizures (HP:0011146) | 2.86771637 |
46 | Postural instability (HP:0002172) | 2.84328099 |
47 | Febrile seizures (HP:0002373) | 2.81723897 |
48 | Premature rupture of membranes (HP:0001788) | 2.78936927 |
49 | Mutism (HP:0002300) | 2.77173647 |
50 | Ketoacidosis (HP:0001993) | 2.75352629 |
51 | Agitation (HP:0000713) | 2.72405198 |
52 | Ventricular fibrillation (HP:0001663) | 2.71822480 |
53 | Anxiety (HP:0000739) | 2.68111457 |
54 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.66659654 |
55 | Exercise-induced myalgia (HP:0003738) | 2.65495811 |
56 | Exercise-induced muscle cramps (HP:0003710) | 2.60793860 |
57 | Muscle stiffness (HP:0003552) | 2.59946673 |
58 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.59349557 |
59 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.59246135 |
60 | Cerebral inclusion bodies (HP:0100314) | 2.57772594 |
61 | Truncal ataxia (HP:0002078) | 2.57533837 |
62 | Lower limb amyotrophy (HP:0007210) | 2.57465291 |
63 | Impaired smooth pursuit (HP:0007772) | 2.55322644 |
64 | EEG with generalized epileptiform discharges (HP:0011198) | 2.54501839 |
65 | Vertebral compression fractures (HP:0002953) | 2.53300680 |
66 | Epileptiform EEG discharges (HP:0011182) | 2.52533121 |
67 | Hypsarrhythmia (HP:0002521) | 2.51274048 |
68 | Urinary urgency (HP:0000012) | 2.48356267 |
69 | Abnormal eating behavior (HP:0100738) | 2.48012571 |
70 | Progressive cerebellar ataxia (HP:0002073) | 2.47990022 |
71 | Difficulty climbing stairs (HP:0003551) | 2.45627034 |
72 | Cerebral aneurysm (HP:0004944) | 2.45572106 |
73 | Axonal loss (HP:0003447) | 2.44983985 |
74 | Slender build (HP:0001533) | 2.43335817 |
75 | Obstructive sleep apnea (HP:0002870) | 2.42502337 |
76 | Thin bony cortex (HP:0002753) | 2.41962364 |
77 | Torticollis (HP:0000473) | 2.40266050 |
78 | Dysmetric saccades (HP:0000641) | 2.39402959 |
79 | Subaortic stenosis (HP:0001682) | 2.37100496 |
80 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.37100496 |
81 | Ankyloglossia (HP:0010296) | 2.36715230 |
82 | Focal dystonia (HP:0004373) | 2.36564555 |
83 | Neoplasm of the heart (HP:0100544) | 2.35805225 |
84 | Neuroendocrine neoplasm (HP:0100634) | 2.35304161 |
85 | Frequent falls (HP:0002359) | 2.35064826 |
86 | Pointed chin (HP:0000307) | 2.34034526 |
87 | Dysdiadochokinesis (HP:0002075) | 2.33571290 |
88 | Bradykinesia (HP:0002067) | 2.31063740 |
89 | Hemiplegia (HP:0002301) | 2.30630535 |
90 | Stridor (HP:0010307) | 2.30485074 |
91 | Abnormality of the calf musculature (HP:0001430) | 2.30213145 |
92 | Insomnia (HP:0100785) | 2.29969554 |
93 | Acanthosis nigricans (HP:0000956) | 2.29898803 |
94 | Ketosis (HP:0001946) | 2.29380069 |
95 | Rapidly progressive (HP:0003678) | 2.29019930 |
96 | Dysmetria (HP:0001310) | 2.28784100 |
97 | Gout (HP:0001997) | 2.27707513 |
98 | Calf muscle hypertrophy (HP:0008981) | 2.26337541 |
99 | Athetosis (HP:0002305) | 2.23661196 |
100 | Global brain atrophy (HP:0002283) | 2.22374563 |
101 | Calcaneovalgus deformity (HP:0001848) | 2.21446559 |
102 | Intention tremor (HP:0002080) | 2.20323435 |
103 | Status epilepticus (HP:0002133) | 2.19858550 |
104 | Generalized amyotrophy (HP:0003700) | 2.19384579 |
105 | Broad-based gait (HP:0002136) | 2.19326498 |
106 | Hypercortisolism (HP:0001578) | 2.19325405 |
107 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.19173086 |
108 | Neurofibrillary tangles (HP:0002185) | 2.16800483 |
109 | Progressive inability to walk (HP:0002505) | 2.16139416 |
110 | Craniofacial dystonia (HP:0012179) | 2.13921052 |
111 | Hyperparathyroidism (HP:0000843) | 2.13755552 |
112 | Foot dorsiflexor weakness (HP:0009027) | 2.12572480 |
113 | Deep palmar crease (HP:0006191) | 2.11981980 |
114 | Amblyopia (HP:0000646) | 2.11160463 |
115 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10932644 |
116 | Annular pancreas (HP:0001734) | 2.10883882 |
117 | Amyotrophic lateral sclerosis (HP:0007354) | 2.09976805 |
118 | Excessive salivation (HP:0003781) | 2.08550314 |
119 | Drooling (HP:0002307) | 2.08550314 |
120 | Fragile skin (HP:0001030) | 2.08022078 |
121 | Spastic gait (HP:0002064) | 2.06609542 |
122 | Abnormal atrioventricular conduction (HP:0005150) | 2.06419027 |
123 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.06231378 |
124 | Oligomenorrhea (HP:0000876) | 2.05323067 |
125 | Stereotypic behavior (HP:0000733) | 2.04558713 |
126 | Hyperacusis (HP:0010780) | 2.03716824 |
127 | Abnormality of oral frenula (HP:0000190) | 2.03332121 |
128 | Myoglobinuria (HP:0002913) | 2.02859774 |
129 | Tetraplegia (HP:0002445) | 2.02440961 |
130 | Shallow orbits (HP:0000586) | 2.01593773 |
131 | Short nail (HP:0001799) | 2.01288009 |
132 | Sudden death (HP:0001699) | 2.00723698 |
133 | Mitral regurgitation (HP:0001653) | 2.00538164 |
134 | Long toe (HP:0010511) | 1.98506971 |
135 | Scapular winging (HP:0003691) | 1.97726589 |
136 | Abnormal EKG (HP:0003115) | 1.95659867 |
137 | Abnormality of the Achilles tendon (HP:0005109) | 1.95603093 |
138 | Upper limb amyotrophy (HP:0009129) | 1.95304309 |
139 | Distal upper limb amyotrophy (HP:0007149) | 1.95304309 |
140 | Achilles tendon contracture (HP:0001771) | 1.94900420 |
141 | Megalencephaly (HP:0001355) | 1.94122382 |
142 | Neuronal loss in central nervous system (HP:0002529) | 1.92189995 |
143 | Rimmed vacuoles (HP:0003805) | 1.91888984 |
144 | Ventricular tachycardia (HP:0004756) | 1.91785727 |
145 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91453280 |
146 | Abnormality of the foot musculature (HP:0001436) | 1.91383735 |
147 | Aortic aneurysm (HP:0004942) | 1.91046680 |
148 | Rigidity (HP:0002063) | 1.90847291 |
149 | Heart block (HP:0012722) | 1.90736249 |
150 | Hypertriglyceridemia (HP:0002155) | 1.90092828 |
151 | Broad face (HP:0000283) | 1.89877305 |
152 | Deformed tarsal bones (HP:0008119) | 1.89277245 |
153 | Unsteady gait (HP:0002317) | 1.88805821 |
154 | Ankle contracture (HP:0006466) | 1.86655996 |
155 | Atrioventricular block (HP:0001678) | 1.85500228 |
156 | Ulnar bowing (HP:0003031) | 1.84523771 |
157 | Psychosis (HP:0000709) | 1.84507717 |
158 | Resting tremor (HP:0002322) | 1.83830120 |
159 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.83799016 |
160 | Apathy (HP:0000741) | 1.82410731 |
161 | Syncope (HP:0001279) | 1.82192299 |
162 | EMG: neuropathic changes (HP:0003445) | 1.81861013 |
163 | Spinal canal stenosis (HP:0003416) | 1.81707223 |
164 | Decreased circulating renin level (HP:0003351) | 1.81580773 |
165 | Back pain (HP:0003418) | 1.80732563 |
166 | Myotonia (HP:0002486) | 1.80109829 |
167 | Ragged-red muscle fibers (HP:0003200) | 1.79650520 |
168 | Scanning speech (HP:0002168) | 1.79203896 |
169 | Absent phalangeal crease (HP:0006109) | 1.78915242 |
170 | Hyperventilation (HP:0002883) | 1.76968125 |
171 | Limb dystonia (HP:0002451) | 1.76110216 |
172 | Restlessness (HP:0000711) | 1.75818910 |
173 | Growth hormone excess (HP:0000845) | 1.75361644 |
174 | Generalized myoclonic seizures (HP:0002123) | 1.74685500 |
175 | Generalized muscle weakness (HP:0003324) | 1.71319913 |
176 | Atrophic scars (HP:0001075) | 1.70575732 |
177 | Easy fatigability (HP:0003388) | 1.69940722 |
178 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.69079788 |
179 | Osteolytic defects of the hand bones (HP:0009699) | 1.69079788 |
180 | Lipoatrophy (HP:0100578) | 1.67439143 |
181 | Progressive muscle weakness (HP:0003323) | 1.65441434 |
182 | Abnormality of the calcaneus (HP:0008364) | 1.64469790 |
183 | Gowers sign (HP:0003391) | 1.63740026 |
184 | Dilated cardiomyopathy (HP:0001644) | 1.63566476 |
185 | Elbow flexion contracture (HP:0002987) | 1.60809510 |
186 | Insulin resistance (HP:0000855) | 1.59584001 |
187 | Wormian bones (HP:0002645) | 1.58948814 |
188 | Abnormal finger flexion creases (HP:0006143) | 1.57061885 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K9 | 4.43696459 |
2 | NTRK3 | 3.97607863 |
3 | EPHA4 | 3.93213298 |
4 | TTN | 3.28057193 |
5 | OBSCN | 2.96601876 |
6 | MINK1 | 2.80943512 |
7 | MARK1 | 2.79996288 |
8 | DAPK2 | 2.69351110 |
9 | KSR2 | 2.56947427 |
10 | SIK1 | 2.35556575 |
11 | IRAK3 | 2.35337391 |
12 | MAP3K4 | 2.28185218 |
13 | PRKD3 | 2.21703045 |
14 | EEF2K | 2.11365799 |
15 | CAMKK1 | 2.10848418 |
16 | TAOK2 | 2.07737146 |
17 | PAK6 | 1.97494346 |
18 | MAP2K3 | 1.91048585 |
19 | NTRK2 | 1.89744125 |
20 | MAP2K4 | 1.87983007 |
21 | TESK1 | 1.83327096 |
22 | SIK2 | 1.80349244 |
23 | ERN1 | 1.79781808 |
24 | MAP2K7 | 1.78677316 |
25 | NTRK1 | 1.78659386 |
26 | ARAF | 1.77957084 |
27 | DAPK1 | 1.75286813 |
28 | KSR1 | 1.69923446 |
29 | TRIB3 | 1.66068660 |
30 | SMG1 | 1.64337302 |
31 | STK38 | 1.63222588 |
32 | MAP3K13 | 1.62818281 |
33 | PKN2 | 1.61482167 |
34 | NME2 | 1.59673139 |
35 | SCYL2 | 1.59589140 |
36 | MAPK12 | 1.53607281 |
37 | ICK | 1.50507342 |
38 | RIPK4 | 1.49550981 |
39 | MAP3K11 | 1.48348049 |
40 | MAPKAPK3 | 1.43541371 |
41 | CDK5 | 1.39712355 |
42 | RIPK1 | 1.30623814 |
43 | TAOK1 | 1.30301597 |
44 | MOS | 1.25895645 |
45 | PHKG2 | 1.21529561 |
46 | PHKG1 | 1.21529561 |
47 | FES | 1.17940092 |
48 | UHMK1 | 1.15649038 |
49 | EPHA2 | 1.14010921 |
50 | LMTK2 | 1.13977151 |
51 | MAP3K2 | 1.13869325 |
52 | CAMKK2 | 1.13173951 |
53 | NEK1 | 1.12021199 |
54 | RET | 1.11311643 |
55 | GRK6 | 1.08097573 |
56 | TNIK | 1.07296596 |
57 | CDK19 | 1.06562797 |
58 | TYRO3 | 1.05542441 |
59 | PRKCH | 1.05082907 |
60 | LATS2 | 1.04998475 |
61 | PRKCG | 1.01096275 |
62 | PRKD2 | 0.97821371 |
63 | MAPK11 | 0.97686317 |
64 | MAP3K3 | 0.95988069 |
65 | ABL2 | 0.93103554 |
66 | IRAK2 | 0.92766442 |
67 | MST1R | 0.90668529 |
68 | MAP3K12 | 0.89299609 |
69 | PDK1 | 0.89128633 |
70 | ILK | 0.88887240 |
71 | PAK3 | 0.85935505 |
72 | MAP3K1 | 0.84745648 |
73 | RAF1 | 0.84553440 |
74 | MAP3K7 | 0.81916717 |
75 | GRK5 | 0.81665446 |
76 | BCKDK | 0.80583280 |
77 | MAPK13 | 0.80506357 |
78 | DDR2 | 0.80349306 |
79 | LIMK1 | 0.79372581 |
80 | STK11 | 0.78221725 |
81 | EPHB2 | 0.77936468 |
82 | PRPF4B | 0.76472986 |
83 | CAMK1 | 0.74095565 |
84 | PDPK1 | 0.72557471 |
85 | ALK | 0.72376888 |
86 | MTOR | 0.72073845 |
87 | CDK14 | 0.71273211 |
88 | CDK15 | 0.70427741 |
89 | CDK18 | 0.70209839 |
90 | PTK2B | 0.69946757 |
91 | DMPK | 0.69031606 |
92 | PRKG2 | 0.67829575 |
93 | TBK1 | 0.67236708 |
94 | CAMK2G | 0.67156790 |
95 | CDK11A | 0.62942847 |
96 | PNCK | 0.62603736 |
97 | PIK3CG | 0.61746154 |
98 | CAMK2A | 0.61737634 |
99 | DAPK3 | 0.61403682 |
100 | NME1 | 0.61395826 |
101 | MYLK | 0.60822200 |
102 | PINK1 | 0.59668837 |
103 | MAP3K6 | 0.59175979 |
104 | SGK223 | 0.56694525 |
105 | SGK494 | 0.56694525 |
106 | MAP2K1 | 0.56078591 |
107 | MARK2 | 0.55809237 |
108 | LRRK2 | 0.55378747 |
109 | DYRK1A | 0.55326560 |
110 | SGK3 | 0.54227620 |
111 | WNK3 | 0.53278250 |
112 | BMX | 0.52008454 |
113 | MAPK4 | 0.51417637 |
114 | PRKCZ | 0.51214830 |
115 | AKT2 | 0.51054445 |
116 | RPS6KA2 | 0.50184874 |
117 | MAP3K10 | 0.49753788 |
118 | MUSK | 0.49392386 |
119 | MET | 0.47985066 |
120 | CSNK1G2 | 0.47922230 |
121 | TGFBR2 | 0.47315905 |
122 | FER | 0.47237377 |
123 | EPHB1 | 0.47148797 |
124 | BRAF | 0.46733293 |
125 | SGK1 | 0.46593285 |
126 | RPS6KA3 | 0.45053656 |
127 | TRPM7 | 0.43072694 |
128 | MAP2K6 | 0.42416872 |
129 | TYK2 | 0.42300574 |
130 | CAMK2B | 0.42198245 |
131 | PTK2 | 0.42195714 |
132 | CAMK1D | 0.41182875 |
133 | SGK2 | 0.41122261 |
134 | CAMK4 | 0.40954543 |
135 | INSRR | 0.40839153 |
136 | PRKCI | 0.40707145 |
137 | PAK4 | 0.40524362 |
138 | PRKAA2 | 0.39937112 |
139 | RPS6KL1 | 0.38841162 |
140 | RPS6KC1 | 0.38841162 |
141 | CDC42BPA | 0.38711965 |
142 | MAPK7 | 0.37474079 |
143 | MAPK10 | 0.37333593 |
144 | NEK9 | 0.37028031 |
145 | PLK2 | 0.36374907 |
146 | FYN | 0.36362521 |
147 | PAK1 | 0.36009942 |
148 | PIM2 | 0.34414422 |
149 | PDGFRB | 0.33954891 |
150 | PDGFRA | 0.33604481 |
151 | MAP3K5 | 0.33425336 |
152 | BRSK1 | 0.33385764 |
153 | CAMK1G | 0.33237199 |
154 | ZAP70 | 0.32566823 |
155 | HIPK2 | 0.32296842 |
156 | PTK6 | 0.31455453 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.93061968 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.69017136 |
3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.61494039 |
4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.59743926 |
5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38040776 |
6 | Insulin secretion_Homo sapiens_hsa04911 | 2.36182953 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.30425157 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27329757 |
9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25085268 |
10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.24719738 |
11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.09673212 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05460572 |
13 | Morphine addiction_Homo sapiens_hsa05032 | 2.01733680 |
14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.00137495 |
15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85734595 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80881379 |
17 | Salivary secretion_Homo sapiens_hsa04970 | 1.76474136 |
18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.75100797 |
19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.75078712 |
20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73597615 |
21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.72133314 |
22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69952285 |
23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.69094265 |
24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.63017294 |
25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51608494 |
26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50001701 |
27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48937244 |
28 | Renin secretion_Homo sapiens_hsa04924 | 1.47031717 |
29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46007348 |
30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.44659065 |
31 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.42661529 |
32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42495751 |
33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34904633 |
34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33391846 |
35 | Taste transduction_Homo sapiens_hsa04742 | 1.31345985 |
36 | Focal adhesion_Homo sapiens_hsa04510 | 1.30707932 |
37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30246347 |
38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27496756 |
39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26268821 |
40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24044669 |
41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23921786 |
42 | Long-term depression_Homo sapiens_hsa04730 | 1.23269107 |
43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23180335 |
44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.22236684 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15581712 |
46 | Bladder cancer_Homo sapiens_hsa05219 | 1.14165797 |
47 | Gap junction_Homo sapiens_hsa04540 | 1.13116659 |
48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10161959 |
49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09601450 |
50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09178473 |
51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.08606444 |
52 | Glioma_Homo sapiens_hsa05214 | 1.08046502 |
53 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07780804 |
54 | Bile secretion_Homo sapiens_hsa04976 | 1.04555072 |
55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03847141 |
56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02419809 |
57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.01756759 |
58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01188356 |
59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00467595 |
60 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.00057753 |
61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99866848 |
62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98218505 |
63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97799839 |
64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95364933 |
65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94140547 |
66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90799814 |
67 | Melanogenesis_Homo sapiens_hsa04916 | 0.90641163 |
68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90476400 |
69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90293724 |
70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89697245 |
71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89200177 |
72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87789137 |
73 | Amoebiasis_Homo sapiens_hsa05146 | 0.87222663 |
74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.86327362 |
75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84373963 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83457858 |
77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82871021 |
78 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82361154 |
79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80809151 |
80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79942245 |
81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.79428802 |
82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77247598 |
83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76009769 |
84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75861481 |
85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72910965 |
86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72755357 |
87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71084824 |
88 | Prion diseases_Homo sapiens_hsa05020 | 0.70175462 |
89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70084543 |
90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69422634 |
91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69395207 |
92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68779687 |
93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67662200 |
94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66909198 |
95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66284664 |
96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66214517 |
97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65963116 |
98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65014126 |
99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63633821 |
100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63484810 |
101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63276887 |
102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62655929 |
103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61312723 |
104 | Lysosome_Homo sapiens_hsa04142 | 0.61144583 |
105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59539516 |
106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58271798 |
107 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57806439 |
108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56697896 |
109 | Hepatitis C_Homo sapiens_hsa05160 | 0.56205902 |
110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56152624 |
111 | Platelet activation_Homo sapiens_hsa04611 | 0.53135329 |
112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52795350 |
113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52698590 |
114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52016394 |
115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51520494 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.50939019 |
117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49152823 |
118 | Endocytosis_Homo sapiens_hsa04144 | 0.49134315 |
119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48817808 |
120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48506960 |
121 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47566695 |
122 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47030990 |
123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46719252 |
124 | Axon guidance_Homo sapiens_hsa04360 | 0.46663707 |
125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45089599 |
126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44811796 |
127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43769974 |
128 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43278517 |
129 | Alcoholism_Homo sapiens_hsa05034 | 0.42673724 |
130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40591413 |
131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40512737 |
132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40165230 |
133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39792088 |
134 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37188693 |
135 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36344097 |
136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35652519 |
137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34681915 |
138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34375792 |
139 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33762853 |
140 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33608592 |